NSC |
Compound |
Enrichment |
Correlation |
NSC 748902 |
[(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] |
0.0434721470609156 |
0.41906254 |
NSC 761822 |
(Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one |
0.0434721470609156 |
0.18428538 |
NSC 761832 |
(Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one |
0.0434721470609156 |
0.29774058 |
NSC 762346 |
Null |
0.0434721470609156 |
0.363474 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.0434721470609156 |
0.55567894 |
NSC 109451 |
Null |
0.0446159312763229 |
-0.18532535 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0446159312763229 |
0.29274967 |
NSC 180973 |
Tamoxifen citrate |
0.0446159312763229 |
0.39650856 |
NSC 201290 |
Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- |
0.0446159312763229 |
0.34644991 |
NSC 266491 |
Psorspermin |
0.0446159312763229 |
0.51278304 |